Renalytix RNLXY
OTC RNLXY
$3.70 -0.09 (-2.37%)
At close: Nov 6, 2026 · 4:00 PM EST

Renalytix (RNLXY) EBITDA (2020 - 2024)

Updated

Renalytix's EBITDA was -$4.03 million in fiscal Q1 2025 (quarter ended Sep 30, 2024), compared with -$8.76 million a year earlier.

Analysis

Renalytix (RNLXY) EBITDA (2020 - 2024) Analysis & Trends

On a trailing twelve-month basis, Renalytix's EBITDA was -$24.52 million through Sep 30, 2024; for FY2024 (ended Jun 30, 2024), it came in at -$29.24 million.

  • In earlier fiscal years, EBITDA was -$41.71 million in FY2023, -$52.69 million in FY2022, -$31.63 million in FY2021 and -$10.25 million in FY2020.
  • The fiscal Q1 2025 figure marks the highest quarterly EBITDA in data going back to fiscal Q2 2021.
  • Per Business Quant data, RNLXY's EBITDA in the three fiscal quarters before Q1 2025 was -$5.47 million (Q4 2024), -$6.48 million (Q3 2024) and -$8.53 million (Q2 2024).
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2024 -4.03 Mn
Jun 30, 2024 -5.47 Mn
Mar 31, 2024 -6.48 Mn
Dec 31, 2023 -8.53 Mn
Sep 30, 2023 -8.76 Mn
Jun 30, 2023 -9.81 Mn
Mar 31, 2023 -10.79 Mn
Dec 31, 2022 -9.52 Mn
Sep 30, 2022 -11.59 Mn
Jun 30, 2022 -12.92 Mn
Mar 31, 2022 -14.41 Mn
Dec 31, 2021 -13.68 Mn
Sep 30, 2021 -11.70 Mn
Jun 30, 2021 -9.73 Mn
Mar 31, 2021 -7.99 Mn
Dec 31, 2020 -8.56 Mn
API Access

Renalytix EBITDA API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebitda&ticker=RNLXY&period=max&api_key=YOUR_API_KEY